Pershing Square Capital Management and Valeant Pharmaceuticals are paying $290 million to settle a lawsuit that alleged their trading in Allergan was illegal, allowing William Ackman to put behind him the last vestiges of an investment that created turmoil at his hedge fund. " News Highlights: Top Company News of the Day" via FOX BIZ http://ift.tt/2BTLS3d
No comments:
Post a Comment